Nicole Marie Pothast, MSN, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 433 W High St, Bryan, OH 43506 Phone: 419-636-1131 Fax: 419-636-3100 |
Mrs. Lindsay Marie Roose, APRN, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 433 W High St, Bryan, OH 43506 Phone: 419-633-0755 Fax: 419-633-0758 |
Katherine Janeway Murphy, APRN, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 442 W High St Ste 3, Bryan, OH 43506 Phone: 419-636-4517 Fax: 419-636-6438 |
News Archive
A new study confirms that chronic kidney disease (CKD) increases the already-high risk of serious cardiovascular events in diabetic patients with damage to the large blood vessels and suggests that treatment with the anti-diabetic drug pioglitazone may help to lower this risk, reports the January Journal of the American Society of Nephrology.
A new way to study the role of a critical neurotransmitter in disorders such as epilepsy, anxiety, insomnia, depression, schizophrenia, and alcohol addiction has been developed by a group of scientists led by Gong Chen, an associate professor of biology at Penn State University.
Agfa HealthCare today reports the Defense Logistics Agency (DLA) has awarded the company a contract to implement and support its enterprise diagnostic imaging solution, IMPAX. IMPAX is Agfa HealthCare's advanced solution for diagnostic radiology imaging, including tools to improve workflow, analysis, and operations for medical imaging management and collaboration.
Calgary dermatologists are inviting members of the public to a free skin cancer screening and sun awareness event at Eau Claire Market, on Friday June 10, 2011, from 10 am to 1 pm.
Researchers have used computational analysis to identify a new Achilles heel for the treatment of drug-resistant breast cancer. The results, which are published in Molecular Systems Biology, reveal that the disruption of glucose metabolism is an effective therapeutic strategy for the treatment of tumours that have acquired resistance to front-line cancer drugs such as Lapatinib.
› Verified 6 days ago